![](/img/cover-not-exists.png)
Integrated analysis of RNA and DNA from a phase III trial of trastuzumab-based neoadjuvant chemotherapy identifies response predictors in HER2-positive breast cancer
Tanioka, Maki, Fan, Cheng, Parker, Joel S., Hoadley, Katherine A., Hu, Zhiyuan, Li, Yan, Hyslop, Terry M., Pitcher, Brandelyn N, Soloway, Matthew G, Spears, Patricia A, Henry, N. Lynn, Tolaney, Sara,Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-17-3431
Date:
July, 2018
File:
PDF, 8.74 MB
english, 2018